• Explore /
  • Poster
  • / Real-time evidence synthesis for first line (1L) treatment of metastatic renal cell carcinoma (mRCC): A living, interactive systematic review and Bayesian network meta-analysis.

Real-time evidence synthesis for first line (1L) treatment of metastatic renal cell carcinoma (mRCC): A living, interactive systematic review and Bayesian network meta-analysis.

Abstract Poster

Authors

null

Syed Arsalan Ahmed Naqvi

Mayo Clinic, Phoenix, AZ

Syed Arsalan Ahmed Naqvi , Huan He , Rabbia Siddiqi , Nihal Ijaz Khan , Kaneez Zahra Rubab Khakwani , Ahsan Ayaz , Parminder Singh , Thai Huu Ho , Alan Haruo Bryce , Bradley Alexander McGregor , Wenxin (Vincent) Xu , Irbaz Bin Riaz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 695)

DOI

10.1200/JCO.2023.41.6_suppl.695

Abstract #

695

Poster Bd #

J8

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Health-related quality of life (HrQoL) of first-line treatments in metastatic renal cell carcinoma (mRCC): A network meta-analysis.

Health-related quality of life (HrQoL) of first-line treatments in metastatic renal cell carcinoma (mRCC): A network meta-analysis.

First Author: Oluseyi Abidoye

First Author: Rabbia Siddiqi

First Author: Umberto Basso

First Author: Irbaz Bin Riaz